{"transactions":[{"id":1665064,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:09.000Z","date":"2024-01-30","kind":"sale","planned":false,"acquired":false,"shares":4825,"price":21.5502,"value":103979.715,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $18.53 to $22.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022."}],"balance_after":38817,"source":{"system":"sec-edgar","filing":"0000950170-24-009493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009493/ownership.xml","form_type":"4"}},{"id":1665063,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:09.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":2758,"price":17.8005,"value":49093.779,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":43642,"source":{"system":"sec-edgar","filing":"0000950170-24-009493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009493/ownership.xml","form_type":"4"}},{"id":1665062,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:09.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":4400,"price":17.8005,"value":78322.2,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":46400,"source":{"system":"sec-edgar","filing":"0000950170-24-009493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009493/ownership.xml","form_type":"4"}},{"id":1687547,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2024-01-04T21:06:24.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":185000,"derivative":{"exercise_price":15.36,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0000950170-24-001843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001843/ownership.xml","form_type":"4"}},{"id":2003303,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2023-02-21T22:08:20.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":185000,"derivative":{"exercise_price":11.99,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-23-011283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011283/doc4.xml","form_type":"4"}},{"id":2003302,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-21T22:08:20.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27."}],"balance_after":50800,"source":{"system":"sec-edgar","filing":"0001209191-23-011283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011283/doc4.xml","form_type":"4"}},{"id":2040214,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-31T22:10:59.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":4840,"price":13.8686,"value":67124.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.62 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022."}],"balance_after":27675,"source":{"system":"sec-edgar","filing":"0001209191-23-005744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123005744/doc4.xml","form_type":"4"}},{"id":2040213,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-31T22:10:59.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":4385,"price":13.8903,"value":60908.9655,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":32515,"source":{"system":"sec-edgar","filing":"0001209191-23-005744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123005744/doc4.xml","form_type":"4"}},{"id":2422416,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2022-01-28T21:10:54.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":261000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":261000,"derivative":{"exercise_price":14.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":261000},"source":{"system":"sec-edgar","filing":"0001209191-22-005367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122005367/doc4.xml","form_type":"4"}},{"id":2422415,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-28T21:10:54.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":36900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26."}],"balance_after":36900,"source":{"system":"sec-edgar","filing":"0001209191-22-005367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122005367/doc4.xml","form_type":"4"}},{"id":2892059,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2021-01-28T22:27:20.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":32.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-005908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121005908/doc4.xml","form_type":"4"}},{"id":3047557,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":94750,"kind":"person","name":"DALE STEPHEN","position":1,"cik":"0001821709","reported_name":"DALE STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2020-08-25T20:25:35.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":21.98,"expiration_date":"2030-08-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-048218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120048218/doc4.xml","form_type":"4"}}]}